Insider Trading activities of Amylin Pharmaceuticals Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amylin Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amylin Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Amylin Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AMLN. The reporting company's CIK number is 881464.
The total value of stock buying since 2005 is $166,931,228.
The total value of stock sales since 2005 is $345,994,933.
The total value of stock option exercises since 2005 is $11,112,250.


Go to page:  1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Amylin Pharmaceuticals Inc insiders (AMLN) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-04-18 Cook Joseph C Jr (Director) Sale 10,000 41.94 419,370
2007-04-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 40.58 271,859
2007-04-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 .55 3,664
2007-04-16 Baron Alain D (Sr VP Research) Sale 1,000 40.55 40,550
2007-04-16 Baron Alain D (Sr VP Research) Option Ex 1,000 5.73 5,730
2007-04-16 Greene Howard E Jr (Director) Sale 3,846 41.46 159,443
2007-04-13 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 40.06 200,300
2007-04-13 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 2.91 14,530
2007-04-13 Baron Alain D (Sr VP Research) Sale 1,000 40.06 40,060
2007-04-13 Baron Alain D (Sr VP Research) Option Ex 1,000 5.73 5,730
2007-04-09 Bradbury Daniel (President & Chief Exec Officer) Sale 2,500 38.66 96,655
2007-04-04 Cook Joseph C Jr (Director) Sale 10,000 37.94 379,440
2007-04-02 Gergen Mark J (Sr VP, Corporate Development) Sale 500 37.47 18,735
2007-04-02 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-04-02 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 36.95 73,900
2007-04-02 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 2,000 11.95 23,900
2007-04-02 Greene Howard E Jr (Director) Sale 3,846 37.12 142,775
2007-03-30 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 37.61 94,025
2007-03-30 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,500 13.25 33,125
2007-03-22 Bradbury Daniel (President & Chief Operating) Option Ex 39,269 10.49 411,892
2007-03-19 Cook Joseph C Jr (Director) Sale 10,000 37.71 377,140
2007-03-19 Greene Howard E Jr (Director) Sale 3,846 37.71 145,048
2007-03-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 38.20 255,926
2007-03-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 .78 5,232
2007-03-07 Bradbury Daniel (President & Chief Operating) Sale 2,500 37.00 92,500
2007-03-05 Cook Joseph C Jr (Director) Sale 10,000 37.20 371,950
2007-03-05 Greene Howard E Jr (Director) Sale 3,846 37.20 143,071
2007-03-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 37.75 18,875
2007-03-01 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-03-01 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 37.39 74,772
2007-03-01 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 2,000 11.95 23,900
2007-02-28 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 38.82 97,050
2007-02-28 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,500 12.60 31,500
2007-02-20 Greene Howard E Jr (Director) Sale 3,846 40.49 155,709
2007-02-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 40.23 269,547
2007-02-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 .78 5,232
2007-02-07 Bradbury Daniel (President & Chief Operating) Sale 3,500 40.52 141,820
2007-02-05 Greene Howard E Jr (Director) Sale 3,846 39.63 152,405
2007-02-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 38.75 19,375
2007-02-01 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-02-01 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 38.92 77,840
2007-02-01 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 2,000 11.95 23,900
2007-02-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 38.68 193,425
2007-02-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 14.38 71,875
2007-01-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 39.00 97,500
2007-01-31 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,500 11.95 29,875
2007-01-22 Greene Howard E Jr (Director) Sale 3,846 39.55 152,101
2007-01-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 41.54 207,710
2007-01-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 .78 3,905
2007-01-11 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 40.00 200,000
2007-01-11 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 3.28 16,405
2007-01-09 Bradbury Daniel (President & Chief Operating) Sale 2,500 38.51 96,275
2007-01-08 Greene Howard E Jr (Director) Sale 3,846 38.16 146,759
2007-01-03 Gergen Mark J (Sr VP, Corporate Development) Sale 500 36.29 18,145
2007-01-03 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-01-03 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 36.10 72,200
2007-01-03 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 5,000 8.84 44,200
2007-01-02 Cook Joseph C Jr (Director) Option Ex 115,479 2.66 306,712
2006-12-29 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 35.89 89,725
2006-12-29 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,500 11.95 29,875
2006-12-26 Greene Howard E Jr (Director) Sale 3,846 36.79 141,509
2006-12-14 Cook Joseph C Jr (Director) Sale 10,000 37.90 378,970
2006-12-14 Cook Joseph C Jr (Director) Option Ex 15,000 13.62 204,375
2006-12-11 Greene Howard E Jr (Director) Sale 3,846 38.44 147,821
2006-12-07 Bradbury Daniel (President & Chief Operating) Sale 2,500 39.35 98,367
2006-12-05 Graham Ginger L (Chief Executive Officer) Option Ex 2,173 23.00 49,979
2006-12-01 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 39.39 78,780
2006-12-01 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 2,000 11.95 23,900
2006-12-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 40.03 200,150
2006-12-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 3.28 16,405
2006-12-01 Eberhard Craig A (VP Sales) Sale 1,000 39.34 39,340
2006-12-01 Eberhard Craig A (VP Sales) Option Ex 1,000 18.85 18,850
2006-12-01 Baron Alain D (Sr VP Research) Sale 2,000 40.01 80,020
2006-12-01 Baron Alain D (Sr VP Research) Option Ex 2,000 5.73 11,460
2006-11-30 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 40.76 101,900
2006-11-30 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,500 11.54 28,842
2006-11-28 Cook Joseph C Jr (Director) Sale 10,000 41.32 413,180
2006-11-27 Greene Howard E Jr (Director) Sale 3,846 40.77 156,816
2006-11-15 Stetsko Gregg (VP Operations) Sale 3,000 44.92 134,760
2006-11-15 Stetsko Gregg (VP Operations) Option Ex 3,000 5.73 17,190
2006-11-13 Cook Joseph C Jr (Director) Sale 10,000 44.77 447,720
2006-11-13 Greene Howard E Jr (Director) Sale 3,846 44.78 172,204
2006-11-07 Bradbury Daniel (President & Chief Operating) Sale 3,000 44.51 133,536
2006-11-07 Baron Alain D (Sr VP Research) Sale 2,000 45.00 90,000
2006-11-07 Baron Alain D (Sr VP Research) Option Ex 2,000 8.43 16,854
2006-11-03 Cook Joseph C Jr (Director) Sale 10,000 43.40 433,960
2006-11-01 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 44.01 88,020
2006-11-01 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 2,000 5.73 11,460
2006-11-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 44.02 220,100
2006-11-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 7.64 38,200
2006-11-01 Eberhard Craig A (VP Sales) Sale 1,000 44.01 44,010
2006-11-01 Eberhard Craig A (VP Sales) Option Ex 1,000 18.85 18,850
2006-11-01 Baron Alain D (Sr VP Research) Sale 2,000 44.02 88,040
2006-11-01 Baron Alain D (Sr VP Research) Option Ex 2,000 5.73 11,460
2006-11-01 Greene Howard E Jr (Director) Sale 10,000 43.90 438,950
2006-10-31 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,500 43.91 109,774
2006-10-31 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,500 11.12 27,812
2006-10-30 Greene Howard E Jr (Director) Sale 3,846 44.15 169,800
2006-10-19 Cook Joseph C Jr (Director) Sale 10,000 46.47 464,730
2006-10-16 Stetsko Gregg (VP Operations) Sale 3,000 46.80 140,400
2006-10-16 Stetsko Gregg (VP Operations) Option Ex 3,000 5.73 17,190
2006-10-16 Greene Howard E Jr (Director) Sale 3,846 47.08 181,058
2006-10-09 Baron Alain D (Sr VP Research) Sale 2,000 45.00 90,000
2006-10-09 Baron Alain D (Sr VP Research) Option Ex 2,000 8.43 16,854
2006-10-06 Bradbury Daniel (President & Chief Operating) Sale 3,000 42.50 127,500
2006-10-05 Cook Joseph C Jr (Director) Sale 10,000 43.65 436,460
2006-10-02 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 43.07 86,146
2006-10-02 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 2,000 5.73 11,460
2006-10-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 43.57 217,845
2006-10-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 12.00 60,000
2006-10-02 Eberhard Craig A (VP Sales) Sale 1,000 43.07 43,073
2006-10-02 Eberhard Craig A (VP Sales) Option Ex 1,000 18.85 18,850
2006-10-02 Baron Alain D (Sr VP Research) Sale 2,000 43.67 87,346
2006-10-02 Baron Alain D (Sr VP Research) Option Ex 2,000 5.73 11,460
2006-10-02 Greene Howard E Jr (Director) Sale 13,846 43.18 597,925
2006-09-21 Cook Joseph C Jr (Director) Sale 10,000 45.50 454,960
2006-09-18 Greene Howard E Jr (Director) Sale 3,846 45.10 173,458
2006-09-15 Stetsko Gregg (VP Operations) Sale 3,000 44.32 132,951
2006-09-15 Stetsko Gregg (VP Operations) Option Ex 3,000 5.73 17,190
2006-09-15 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,000 44.35 88,700
2006-09-15 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,000 10.50 21,000
2006-09-08 Bradbury Daniel (Chief Operating Officer) Sale 4,222 44.25 186,822
2006-09-06 Cook Joseph C Jr (Director) Sale 10,000 46.06 460,570
2006-09-05 Greene Howard E Jr (Director) Sale 3,846 46.48 178,773
2006-09-01 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 45.21 90,420
2006-09-01 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 2,000 5.66 11,320
2006-09-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 46.14 230,685
2006-09-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 12.00 60,000
2006-09-01 Eberhard Craig A (VP Sales) Sale 1,500 45.21 67,815
2006-09-01 Eberhard Craig A (VP Sales) Option Ex 1,500 18.85 28,275
2006-09-01 Baron Alain D (Sr VP Research) Sale 5,000 45.94 229,700
2006-09-01 Baron Alain D (Sr VP Research) Option Ex 5,000 7.08 35,390
2006-09-01 Greene Howard E Jr (Director) Sale 10,000 46.10 460,970
2006-08-28 Greene Howard E Jr (Director) Sale 3,846 45.96 176,766
2006-08-25 Cook Joseph C Jr (Director) Sale 10,000 45.33 453,320
2006-08-21 Greene Howard E Jr (Director) Sale 3,846 46.11 177,323
2006-08-15 Foletta Mark G (Senior VP, Finance & CFO) Sale 2,000 41.76 83,520
2006-08-15 Foletta Mark G (Senior VP, Finance & CFO) Option Ex 2,000 9.88 19,750
2006-08-14 Greene Howard E Jr (Director) Sale 3,846 41.56 159,847
2006-08-11 Cook Joseph C Jr (Director) Sale 20,000 41.18 823,560
2006-08-07 Bradbury Daniel (Chief Operating Officer) Sale 3,000 47.41 142,230
2006-08-07 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 46.93 234,640
2006-08-07 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 12,093 7.64 92,390
2006-08-07 Baron Alain D (Sr VP Research) Sale 1,000 47.41 47,410
2006-08-07 Baron Alain D (Sr VP Research) Option Ex 1,000 7.19 7,187
2006-08-01 Rowland Lloyd A (VP Legal & General Counsel) Sale 2,000 47.43 94,862
2006-08-01 Rowland Lloyd A (VP Legal & General Counsel) Option Ex 2,000 5.59 11,180
2006-08-01 Eberhard Craig A (VP Sales) Sale 1,500 47.42 71,136
2006-08-01 Eberhard Craig A (VP Sales) Option Ex 1,500 18.85 28,275
2006-08-01 Baron Alain D (Sr VP Research) Sale 3,000 48.28 144,840
Go to page:  1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of AMLN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amylin Pharmaceuticals Inc (symbol AMLN, CIK number 881464) see the Securities and Exchange Commission (SEC) website.